Gupta, Dablu Lal, Jhasketan Meher, Anjan Kumar Giri, Arvind Kumar Shukla, Eli Mohapatra, Manisha M Ruikar, and DN Rao. “RBD Mutations at the Residues K417, E484, N501 Reduced Immunoreactivity With Antisera from Vaccinated and COVID-19 Recovered Patients”. Drug Target Insights 18, no. 1 (May 31, 2024): 20–26. Accessed July 20, 2024. https://journals.aboutscience.eu/index.php/dti/article/view/3059.